Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Depreciation and Depletion (2019 - 2025)

Keros Therapeutics filings provide 7 years of Depreciation and Depletion readings, the most recent being $400000.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion rose 20.48% to $400000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 22.78% increase, with the full-year FY2025 number at $1.5 million, up 22.78% from a year prior.
  • Depreciation and Depletion hit $400000.0 in Q4 2025 for Keros Therapeutics, up from $395000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $400000.0 in Q4 2025 to a low of $80000.0 in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $228500.0 (2023), compared with a mean of $230250.0.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 238.46% in 2022 and later crashed 37.99% in 2023.
  • Keros Therapeutics' Depreciation and Depletion stood at $104000.0 in 2021, then grew by 22.12% to $127000.0 in 2022, then surged by 94.49% to $247000.0 in 2023, then skyrocketed by 34.41% to $332000.0 in 2024, then rose by 20.48% to $400000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $400000.0 (Q4 2025), $395000.0 (Q3 2025), and $370000.0 (Q2 2025) per Business Quant data.